The 12,000 Shares of Stryker Corp. (SYK) Stock are sold by Yin C. Becker

The 12,000 Shares of Stryker Corp. (SYK) Stock are sold by Yin C. Becker

Stryker Corp. (NYSE:SYK) VP Yin C. Becker sold 12,000 shares of the business’s stock in a transaction on Wednesday, October 12th. The shares were sold at an average price of $114.03, for a total transaction of $1,368,360.00. Following the completion of the sale, the vice president now owns 28,939 shares in the company, valued at approximately $3,299,914.17. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Stryker Corp. (NYSE:SYK) opened at 113.57 on Tuesday. The firm’s 50-day moving average price is $115.20 and its 200-day moving average price is $114.25. Stryker Corp. has a 52-week low of $86.68 and a 52-week high of $123.55. The firm has a market cap of $42.51 billion, a P/E ratio of 26.77 and a beta of 0.72.

Stryker Corp. (NYSE:SYK) last posted its earnings results on Thursday, July 21st. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.37 by $0.02. The firm earned $2.84 billion during the quarter, compared to the consensus estimate of $2.79 billion. Stryker Corp. had a return on equity of 23.61% and a net margin of 15.33%. Equities research analysts expect that Stryker Corp. will post $5.76 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 31st. Shareholders of record on Friday, September 30th will be given a $0.38 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $1.52 annualized dividend and a yield of 1.34%. Stryker Corp.’s dividend payout ratio is presently 35.85%.

A number of institutional investors have recently bought and sold shares of the stock. Lazard Asset Management LLC purchased a new position in Stryker Corp. during the first quarter valued at approximately $272,490,000. Winslow Capital Management LLC bought a new position in shares of Stryker Corp. during the second quarter worth about $174,599,000. Capital Research Global Investors increased its position in shares of Stryker Corp. by 3.4% in the second quarter. Capital Research Global Investors now owns 32,980,782 shares of the medical technology company’s stock worth $3,952,087,000 after buying an additional 1,095,549 shares during the period. BlackRock Fund Advisors increased its position in shares of Stryker Corp. by 20.1% in the second quarter. BlackRock Fund Advisors now owns 6,280,516 shares of the medical technology company’s stock worth $752,594,000 after buying an additional 1,051,648 shares during the period. Finally, Emerald Acquisition Ltd. bought a new position in shares of Stryker Corp. during the second quarter worth about $104,111,000. Hedge funds and other institutional investors own 75.50% of the company’s stock.

SYK has been the topic of several recent analyst reports. SunTrust Banks Inc. initiated coverage on shares of Stryker Corp. in a research note on Thursday, October 13th. They issued a “buy” rating and a $140.00 target price on the stock. Zacks Investment Research cut Stryker Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, September 27th. Needham & Company LLC reaffirmed a “hold” rating on shares of Stryker Corp. in a report on Sunday, July 24th. Piper Jaffray Cos. lifted their price target on Stryker Corp. from $120.00 to $135.00 and gave the company an “overweight” rating in a report on Friday, July 22nd. Finally, Brean Capital reaffirmed a “buy” rating and issued a $125.00 price target (up from $121.00) on shares of Stryker Corp. in a report on Monday, July 25th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $117.91.

About Stryker Corp.

Related posts

Leave a Comment